![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FRANCE'S INNATE PHARMA SIGNS DEAL WITH SCHERING-PLOUGH
FRANCE'S INNATE PHARMA SIGNS DEAL WITH SCHERING-PLOUGH
Privately held French biotech company Innate Pharma on Monday said it has signed a deal with U.S.-based Schering-Plough Corp. (SGP) to in-license some assets for developing toll-like receptors, or TLRs, which can help activate the body's adaptive immune system.
Market
Watch
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct